Hypothalamic dopamine (DA) tonically inhibits prolactin (PRL) release from the anterior pituitary gland. Transient escapes from this DA tone elicit a pronounced potentiation of the PRL-releasing action of secretagogues such as thyrotropin-releasing hormone (TRH). Previous evidence has suggested that modulation of Ca2+ channels can be involved in this potentiation. With a lactotropic cell line (GH4C1) expressing human D2-DA receptors, we tested the hypothesis that a brief escape from the tonic inhibitory action of DA triggers a facilitation of Ca2+ influx through Ca2+ channels. We initially found that in these cells, DA effectively and reversibly inhibited PRL secretion, and reversibly enhanced an inwardly rectifying K+ current. The effects of DA administration and withdrawal on Ca2+ currents were examined using the patch-clamp technique in the whole-cell configuration and Ba2+ as a divalent charge carrier through Ca2+ channels. Macroscopic Ba2+ currents were significantly decreased by short term (1–10 min) applications of DA (500 nM), which further declined following 24 h of constant exposure to DA. After DA removal, a biphasic facilitation of the density of Ba2+ currents was observed. An initial 2-fold enhancement of conductance was detected between 10 and 40 min, followed by a second facilitation of the same magnitude observed 24 h after DA withdrawal. The present results directly demonstrate that dissociation of DA from D2-receptors expressed in GH4C1 lactotrope cells causes an increase of high-voltage-activated Ca2+ channel function, which may play an important role in the cross-talking amplification of endocrine cascades such as that involved in the TRH-induced PRL-release potentiating action of DA withdrawal.
Modulation of Ca2+ channels has been shown to alter cellular functions. It can play an important role in the amplification of signals in the endocrine system, including the pleiotropically regulated pituitary lactotropes. Prolactin (PRL) secretion is tonically inhibited by dopamine (DA), the escape from which triggers acute episodes of hormone secretion. The magnitude of these episodes is explained by a potentiation of the PRL-releasing action of secretagogues such as thyrotropin-releasing hormone (TRH). While the mechanisms of this potentiation are not fully understood, it is known to be mimicked by the dihydropyridine, L-type Ca2+ channel agonist Bay K 8644 and blocked by nifedipine and methoxyverapamil. The potentiation is also blocked by inhibitors of cyclic AMP-dependent protein kinase and protein kinase C. We recently described that the escape from tonic actions of DA results in increased macroscopic Ca2+ currents in GH4C1 lactotropic clonal cells transfected with a cDNA encoding the long form of the human D2-DA receptor. Here we show that the withdrawal from DA potentiates the PRL-releasing action of TRH in GH4C1/D2-DAR cells to the same extent as in enriched lactotropes in primary culture. In both experimental models a low density of dihydropyridine receptors was shown by (+)-[3H]PN200-110 binding. Photoaffinity labelling with the dihydropyridine [3H]azidopine revealed a protein consistent with the α1 subunit of L-type Ca2+ channels of 165–170 kDa. In both experimental models, the facilitation of TRH action triggered by the escape from DA was correlated with an enhanced rate of phosphorylation of this putative α1 subunit, the nature of which was further supported by immunoprecipitation with selective antibodies directed against the α1C and α1D subunit of voltage-gated calcium channels. We propose that PKA- and PKC-dependent phosphorylation of the α1 subunit of high voltage activated, L-type Ca2+ channels is responsible for the facilitation of Ca2+ currents in lactotropes, and hence for the potentiation of secretagogue-mediated PRL secretion. Thus, phosphorylation of Ca2+ channels in endocrine cells may be a mechanism for the regulation of various functions including amplification of hormone secretion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.